期刊文献+

卡维地洛治疗慢性心力衰竭患者对血浆脑钠肽的影响

卡维地洛治疗慢性心力衰竭患者对血浆脑钠肽的影响
暂未订购
导出
摘要 目的观察卡维地洛治疗慢性心力衰竭(CHF)后对患者血浆脑钠肽(BNP)的影响。方法86例慢性心力衰竭心功能在Ⅱ~Ⅳ级患者,在常规心力衰竭治疗基础上,加用卡维地洛,观察治疗前后BNP水平变化。结果血压下降,心率减慢,心胸比缩小.左室舒张朱期内径(LVDd)缩短,左室射血分数(LVEF)提高,BNP水平显著降低。结论卡维地洛治疗慢性心力衰竭(CHF)可使BNP值明显下降,增加LVEF,缩小左室内径,改善心功能,BNP水平与LVEF呈显著负相关,可作为诊断心衰和了解预后的指标。 Objective To observe plasma brain nutriuretic peptide level of patient with congestive heart failure (CHF) treated with low dose Carvedilol. Methods Chose 86 heart failure patients with Ⅱ-Ⅳ New York Heart Association (NYHA) functional classification, and used carvedilol on the basis of traditional treatment, then observe the change in the plasma brain natriuretic peptide level during the treatment. Results After the treatment, patients' heart rate, blood pressure, cardio-thoracic ratio and LVDd all defined,but LVEF increased. The value of BNP declined significantly. Conclusion The value of BNP declined obviously after the use of carvedilol, which may help to increase LVEF, reduce the left ventricular diameter and improve the heart function. BNP level presented a negative correlation with LVEF, which can be used as index for diagnosis and prediction.
出处 《当代医学》 2008年第6期68-69,共2页 Contemporary Medicine
关键词 慢性心力衰竭 卡维地洛 脑钠肽 CFH Carvedilol BNP
  • 相关文献

参考文献1

二级参考文献14

  • 1Cohn JN. Prognositc factors in heart failure: P poverty amidst a wealth of variables. J Am Coil Cardiol, 1989,14:571-572.
  • 2Kelly TL,Cremo R,Nieosen C,et al. Prediction of outcome in late-stage cardiomyopathy. Am Heart J, 1990,119:1111-1121.
  • 3ACC/AHA. Guidelines for the Evaluathin and management of chronic heart failure in the adut: execative summmary. Circulation, 2001,104:2996-3007.
  • 4Task force for the diagnosis and treatment of chronic heart failure of european society of cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J,2001,22 :1527-1560.
  • 5Sudoh T, Kangawa K, Minamino N, et al. A-natiuretic peptide in porcine brain. Nature, 1988,322: 78 -81.
  • 6Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure:prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricu
  • 7Chen HH, Burnett JC. Natriuretic peptides in the pathophysiology of congestive heart failure. Curr Cardiol Rep ,2000,2:198-205.
  • 8Morrison KL,Harrison A,Krishnaswamy P,et al. Utility of a rapid B-natriuretic peptide(BNP) assay in differentiating CHF from lung disease in patients presenting with dyspnea. J Am Coll Cardiol, 2002,39: 202-209.
  • 9Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure.N Engl J Med,1999,341:577-585.
  • 10Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med, 1998,339:321-328.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部